STOCKHOLM, Sweden, June 12, 2001 (PRIMEZONE) -- As announced earlier, the last day for conversion of Elekta's (SSE:EKTAB) convertible debentures is Friday June 29, 2001.
Up to now debentures totaling SEK 58,504,285 have been applied for conversion corresponding to 971,832 B-shares. Of these, the Swedish Patent and Registration Office has, on June 8, registered 550,764 new series B-shares corresponding to an increase in share capital of SEK 2,753,820. After this increase, the total number of series B-shares amounts to 27,216,881 and the total number of shares, including series A-shares, amounts to 28,404,381. This includes applications to convert received until May 29, 2001.
Elekta is a world-leading supplier of advanced and innovative radiation oncology and neurosurgery solutions and services for precise treatment of cancer and brain disorders. Elekta's solutions are clinically effective, cost efficient and gentle to the patient.
More information about Elekta can be found at: www.elekta.com